Click here for an archive of Cramer's "Mad Money" recaps.
The Eyes Have It
It's time to buy the greatest medical stock you've never heard, Jim Cramer told his "Mad Money" TV show viewers Thursday, and that stock is
People aren't just paying for vanity as they age, they'd also like to be able to see, Cramer said. But those who suffer from age-related macular degeneration are losing their eyesight.
There are treatments on the market for wet macular degeneration, but there's really nothing out there for dry macular degeneration, which usually comes first.
But OccuLogix has a blood filtration procedure to treat dry macular degeneration, and Cramer said that this could mean mad money.
Cramer said there were no vitamin plays that could offer the kind of returns OccuLogix may someday unleash, but he added that the stock was speculative. So Cramer emphasized that it would be important to use limit orders.
Just Don't Short Us
Back in September Cramer told viewers to buy
at $2; the stock has gained more than 39%.
If Cramer had bought it at that price, he said he'd probably take a little off the top now, because "
bulls make money, bears make money, but pigs get slaughtered."
But if you didn't get in then, the stock is still a buy, particularly once the price retreats back to $2.50 from its current $2.79.
Of all the reasons Cramer thinks viewers should own JDSU, he said that positive analyst coverage will unleash some real upside for the stock. Lehman Brothers upgraded the stock, and it rose 12%, he said.
By buying communications test and measurement company
, JDSU has diversified away from a pure telecommunications play and gotten better gross margins, Cramer said. And its optical component business is turning around and is on fire.
"This stock's been tearing the shorts to pieces," he said.
Even though he was excited about JDSU, Cramer told a caller that he didn't see any great broadband-over-power-line plays right now.
Red Tape in China
While Cramer wouldn't stand behind any telecom plays in China, he saw other opportunities in the Middle Kingdom, with the Chinese government saying it will spend trillions of dollars to beef up the country's energy and transport sectors.
"This is a situation where it could pay to make an educated guess," Cramer said, adding that he believes that engineering and construction companies will benefit from all these new infrastructure projects.
He said that of all the plays out there,
is one of two American engineering companies incorporated in China. That means a lot less red tape standing between them and the money.
Moreover, he said he'd buy Fluor without the China angle because it's a strong company with 28% revenue growth over the last 12 months, low debt and a lot of cash.
No Place Like Homeland
Cramer wrapped up the show with what he called the best in homeland security and domestic security buys, welcoming Bob LaPenta, chairman of
to the show.
just agreed to acquire
for $770 million in stock, a move that LaPenta said would integrate key law enforcement and homeland security products under a single platform.
Viisage already had the market on driver's licenses and passport security products, the key documents for U.S. security. And both companies offered face-recognition technology.
But LaPenta said that Identix brought fingerprint identification -- the most commonly used biometric identifier -- to the company and that Viisage has brought great management to a crowded field.
To view Cramer's interview with LaPenta, click here.
Cramer was bullish on
Allscripts Healthcare Solutions
Cramer was bearish on
For more of Cramer's insights during the Lightning Round, click here
Want more Cramer? Check out Jim's rules and commandments for investing from his latest book by
As originally published, this story contained an error. Please see
Corrections and Clarifications.
Jim Cramer, host of the CNBC television program "Mad Money," is a Markets Commentator for TheStreet.com, Inc., and CNBC, and a director and co-founder of TheStreet.com. All opinions expressed by Mr. Cramer on Mad Money are his own and do not reflect the opinions of TheStreet.com or its affiliates, or CNBC, NBC UNIVERSAL or their parent company or affiliates. Mr. Cramer's opinions are based upon information he considers to be reliable, but neither TheStreet.com, nor CNBC, nor either of their affiliates and/or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. Mr. Cramer's statements are based on his opinions at the time statements are made, and are subject to change without notice. No part of Mr. Cramer's compensation from CNBC or TheStreet.com is related to the specific opinions expressed by him on "Mad Money."
None of the information contained in "Mad Money" constitutes a recommendation by Mr. Cramer, TheStreet.com or CNBC that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the program. Mr. Cramer's past results are not necessarily indicative of future performance. Neither Mr. Cramer, nor TheStreet.com, nor CNBC guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the program. The strategy or investments discussed may fluctuate in price or value and you may get back less than you invested. Before acting on any information contained in the program, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.
Some of the stocks mentioned by Mr. Cramer on "Mad Money" are held in Mr. Cramer's Action Alerts PLUS Portfolio. The Action Alerts PLUS Portfolio contains all of Mr. Cramer's personal investments in publicly-traded equity securities only, and does not include any mutual fund holdings or other institutionally managed assets, private equity investments, or his holdings in TheStreet.com, Inc. Since March 2005, the Action Alerts PLUS Portfolio has been held by a Trust, the realized profits from which have been pledged to charity. Mr. Cramer retains full investment discretion with respect to all securities contained in the Trust. Mr. Cramer is subject to certain trading restrictions, and must hold all securities in the Action Alerts PLUS Portfolio for at least one month, and is not permitted to buy or sell any security he has spoken about on television or on his radio program for five days following the broadcast.